AzTrials
AzTrials

Pancreas NecrosisPROMETHEUSNCT03100578

EUS-guided Transmural Drainage of Walled-off Pancreatic Necrosis: Plastic vs Metallic Protesis.

A study testing WOPN TRANSMURAL DRAINAGE: PLASTIC STENT and WOPN TRANSMURAL DRAINAGE: METALLIC STENT in people with Pancreas Necrosis and Pancreatic Collection, run by Hospital Universitari de Bellvitge at 8 sites in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Randomized multicenter study comparing plastic stents and self-expanding metallic stents in the eus-guided transmural drainage of walled-off pancreatic necrosis. Spanish centers partners of the spanish society of digestive endoscopy. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Pancreas Necrosis, Pancreatic Collection
What is being tested?
WOPN TRANSMURAL DRAINAGE: PLASTIC STENT and WOPN TRANSMURAL DRAINAGE: METALLIC STENT
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
99 participants
Where
8 sitesSpain
Study dates
27 Jun 2017to 30 Oct 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age greater than or equal to 18 years
  • Patient with indication (ASGE, Jacobson BC, GIE2005;) of pancreatic collection drainage type WALLED-OFF PANCREATIC NECROSIS * as a local complication of previous acute pancreatitis.
  • Patient trained to understand and / or sign informed consent
  • Patient who understands the type of study and will comply with all follow-up of complementary tests during its duration

Who cannot join

  • Pregnancy or breastfeeding
  • Severe coagulation disorder: INR> 1.5 not correctable with plasma and / or platelet administration <50,000 / mm3
  • Asymptomatic patients, with no clinical indication of drainage, except for those with vascular involvement due to compression (eg stenosis, splenic vessels with collateral circulation, and risk of bleeding)
  • Non-identification of solid content during the Endoscopic Ultrasound of the procedure
  • No informed consent
  • In the case of patients with mental retardation, without the ability to understand the nature and possible consequences of the study, except for the existence of a legal representative
  • Patients unable to maintain posterior follow-up (lack of adherence)
  • Situations that do not allow the practice of a high digestive endoscopy (eg, stenosis)

Trial locations and contacts

8 sites in 1 country.

8 sites in 1 country

Spain8 sites
  • Hospital de la Santa Creu i Sant Pau

    Barcelona, 08041

  • Hospital Arnau de Vilanova

    Lleida, Barcelona, 25198

  • Hospital Universitario Ramón y Cajal

    Madrid, 28034

  • Hospital Clínico San Carlos

    Madrid, 28040

  • Hospital Costa del Sol

    Marbella, Málaga, 29603

  • Hospital San Juan de Dios

    Pamplona, Navarre, 31006

  • Hospital Universitario Marqués de Valdecilla

    Santander, Cantabria, 39008

  • Hospital Universitario Río Hortega

    Valladolid, Valldolid, 47012

Other trials in Spain

About this study

Official title: Randomized Multicenter Study Comparing Plastic Stents and Self-expanding Metallic Stents Used in the Eus-guided Transmural Drainage of Walled-off Pancreatic Necrosis.

Randomized multicenter study comparing plastic stents and self-expanding metallic stents in the eus-guided transmural drainage of walled-off pancreatic necrosis.

Spanish centers partners of the spanish society of digestive endoscopy.

Being tested
WOPN TRANSMURAL DRAINAGE: PLASTIC STENT, WOPN TRANSMURAL DRAINAGE: METALLIC STENT
Keywords
PANCREAS, ENDOSCOPIC INTERVENTION, PLASTIC STENT, SELF EXPANDING METALLIC STENT, ENDOSCOPIC TRANSMURAL DRAINAGE, WALLED OFF PANCREATIC NECROSIS
Medical subject headings
Pancreatitis, Acute Necrotizing

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • WOPN TRANSMURAL DRAINAGE: PLASTIC STENTDevice

    Endoscopic ultrasound-guided transmural drainage of walled-off pancreatic necrosis:

    The pancreatic collection will be located with the linear echoendoscope, and we will proceed to choose an optimal area to perform the puncture guided by EUS; with the absence of intervening vessels.

    This collection will be punctured with a 19 G needle or with an electrocautery device directly. Guidance will be advanced through the needle and the ostomy will proceed according to the routine of the experienced endoscopist.

    Placement of a plastic double pigtail, 5-10 cm in length, diameters 7-8,5-10 Fr. Minimum one 10 Fr prosthesis.

    Arm associated: PLASTIC STENT

  • WOPN TRANSMURAL DRAINAGE: METALLIC STENTDevice

    Endoscopic ultrasound-guided transmural drainage of walled-off pancreatic necrosis:

    The pancreatic collection will be located with the linear echoendoscope, and we will proceed to choose an optimal area to perform the puncture guided by EUS; with the absence of intervening vessels.

    This collection will be punctured with a 19 G needle or with an electrocautery device directly. Guidance will be advanced through the needle and the ostomy will proceed according to the routine of the experienced endoscopist.

    Placement of a metal self-expanding fully covered luminal apposition stent: 10, 15 or 20 mm diameter.

    Arm associated: SELF EXPANDABLE METALLIC STENT

Study groups in NCT03100578
Study groupRoleWhat they receive
PLASTIC STENTExperimentalEndoscopic double pigtail plastic stent, with formal indication on pancreatic collection, according to the instruction forms of the manufacturer. Interventions associated: EUS-guided transmural drainage of pancretic collection: PLASTIC STENT.
Receives: Device: WOPN TRANSMURAL DRAINAGE: PLASTIC STENT
SELF EXPANDABLE METALLIC STENTActive comparatorLumen apposing metal stent with formal indicaction on pancreatic collection, according to the manufacturer instruction forms. Interventions associated: EUS-guided transmural drainage of pancretic collection: METALLIC STENT.
Receives: Device: WOPN TRANSMURAL DRAINAGE: METALLIC STENT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. RADIOLOGICAL SUCCESS

    Radiological success at 4 weeks after the interventional procedure: reduction size of the wopn at least 50%.

    Measured: 4 weeks

Secondary outcomes (5)
  1. CLINICAL SUCCESS

    Evaluate the long-term clinical success (4 months) (metallic vs. plastic) determined by the total resolution or <3cm of the WOPN, releated with clinical improvement.

    Measured: 4 month

  2. TECHNICAL ASPECTS

    Evaluate the technical success, duration of the procedure and level of difficulty.

    Measured: 1st day

  3. INCIDENCE OF TREATMENT-EMERGENT ADVERSE EVENTS [SAFETY AND TOLERABILITY]

    Assess safety: complications (immediate, early and late)

    Measured: 1st day, 24h, 7 days, 4 weeks, 8 weeks, 4 month, 6 month, 8 month, 12 month

  4. RECURRENCES

    Evaluate recurrences

    Measured: 4 weeks, 8 weeks, 4 month, 6 month, 8 month, 12 month

  5. COSTS ANALYSIS

    Evaluate the costs between the two types of strategy

    Measured: 12 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Apr 2017
  2. Study start27 Jun 2017
  3. Primary completion30 Oct 2021
  4. Study completion30 Oct 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
99 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03100578
Sponsor's protocol ID
PROMETHEUS
Acronym
PROMETHEUS
Status last verified
Nov 2021
First submitted
29 Mar 2017
Last updated
10 Nov 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Gornals JB, Velasquez-Rodriguez JG, Bas-Cutrina F, Garcia Garcia De Paredes A, Esteban JM, Teran A, Gonzalez-Huix F, Perez-Miranda M, Guarner-Argente C, Vila JJ, Garcia-Sumalla A, Foruny JR, Fisac-Vazquez J, Moris M, Miquel-Salas I, De-la-Serna Higuera C, Murzi-Pulgar M, Sanchez-Yague A, Salord S, Ruiz-Osuna S, Busquets J, Sanllorente-Melenchon M, Videla S, Moreno R, Tebe-Cordomi C, Hereu P, Vazquez-Sequeiros E; Spanish Working Group on Pancreatic Collection Therapy. Plastic pigtail vs lumen-apposing metal stents for drainage of walled-off necrosis (PROMETHEUS study): an open-label, multicenter randomized trial. Surg Endosc. 2024 Apr;38(4):2148-2159. doi: 10.1007/s00464-024-10699-w. Epub 2024 Mar 6.

    PubMed 38448625
  • Gornals JB, Perez-Miranda M, Vazquez-Sequeiros E, Vila J, Esteban JM, Gonzalez-Huix F, Guarner-Argente C, Sanchez-Yague A, Teran A, Bas-Cutrina F, De La Serna C, De Paredes AG, Ballester R, Velasquez-Rodriguez J, Salord S, Tebe C, Hereu P, Videla S; Spanish Working Group on Pancreatic Collection Therapy. Multicenter study of plastic vs. self-expanding metal stents in endoscopic ultrasound-guided drainage of walled-off pancreatic necrosis - PROMETHEUS: a randomized controlled trial protocol. Trials. 2019 Dec 30;20(1):791. doi: 10.1186/s13063-019-3988-x.

    PubMed 31888751

Questions about this trial

What is this clinical trial studying?

A study testing WOPN TRANSMURAL DRAINAGE: PLASTIC STENT and WOPN TRANSMURAL DRAINAGE: METALLIC STENT in people with Pancreas Necrosis and Pancreatic Collection, run by Hospital Universitari de Bellvitge at 8 sites in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Nov 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 8 sites in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

RADIOLOGICAL SUCCESS (time frame: 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03100578, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Nov 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in